Monday, July 19, 2010

Follow-up on the FDA Avandia Hearings: "GlaxoSmithKline...can't be trusted"

I have not been posting specifically on the FDA Avandia hearings of this past week, focusing rather on some important background that I believed the popular media were missing. The gap was very nicely filled by my esteemed colleague Roy Poses over at Health Care Renewal blog, whose comprehensive and thoughtful post I commend to your attention:

As to one of the main findings that came out of the hearings, the degree to which the manufacturer twisted and turned with the data to prevent bad news about Avandia from seeing daylight, one main bit of news coverage is by Gardiner Harris in the New York Times:

And the quote with which I began this post about "can't be trusted" is taken from a New York Times editorial:

No comments: